HRP970099B1 - Peptide derivatives - Google Patents

Peptide derivatives

Info

Publication number
HRP970099B1
HRP970099B1 HR970099A HRP970099A HRP970099B1 HR P970099 B1 HRP970099 B1 HR P970099B1 HR 970099 A HR970099 A HR 970099A HR P970099 A HRP970099 A HR P970099A HR P970099 B1 HRP970099 B1 HR P970099B1
Authority
HR
Croatia
Prior art keywords
peptide derivatives
peptide
derivatives
Prior art date
Application number
HR970099A
Other languages
English (en)
Inventor
Ronald Cotton
Philip Neil Edwards
Richard William Arthur Luke
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603855.9A external-priority patent/GB9603855D0/en
Priority claimed from GBGB9620819.4A external-priority patent/GB9620819D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of HRP970099A2 publication Critical patent/HRP970099A2/hr
Publication of HRP970099B1 publication Critical patent/HRP970099B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR970099A 1996-02-23 1997-02-21 Peptide derivatives HRP970099B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603855.9A GB9603855D0 (en) 1996-02-23 1996-02-23 Peptide derivatives
GBGB9620819.4A GB9620819D0 (en) 1996-10-05 1996-10-05 Chemical compounds

Publications (2)

Publication Number Publication Date
HRP970099A2 HRP970099A2 (en) 1998-04-30
HRP970099B1 true HRP970099B1 (en) 2001-10-31

Family

ID=26308795

Family Applications (1)

Application Number Title Priority Date Filing Date
HR970099A HRP970099B1 (en) 1996-02-23 1997-02-21 Peptide derivatives

Country Status (29)

Country Link
US (1) US6087336A (xx)
EP (1) EP0882066B1 (xx)
JP (1) JP3468528B2 (xx)
KR (1) KR19990087123A (xx)
CN (1) CN1116305C (xx)
AR (1) AR005974A1 (xx)
AT (1) ATE196152T1 (xx)
AU (1) AU722877C (xx)
BR (1) BR9707720A (xx)
CA (1) CA2242809A1 (xx)
CZ (1) CZ266398A3 (xx)
DE (1) DE69703032T2 (xx)
DK (1) DK0882066T3 (xx)
ES (1) ES2151716T3 (xx)
GB (1) GB9702377D0 (xx)
GR (1) GR3034361T3 (xx)
HK (1) HK1015383A1 (xx)
HR (1) HRP970099B1 (xx)
HU (1) HU222198B1 (xx)
ID (1) ID16037A (xx)
IL (1) IL125804A0 (xx)
NO (1) NO983849L (xx)
NZ (1) NZ330944A (xx)
PL (1) PL328486A1 (xx)
PT (1) PT882066E (xx)
SK (1) SK114998A3 (xx)
TR (1) TR199801614T2 (xx)
TW (1) TW492978B (xx)
WO (1) WO1997031023A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
NZ332347A (en) * 1996-06-07 2000-05-26 Zeneca Ltd Peptide derivatives containing a hydrophobic group, L-amino acid residues and modified L-amino acid residues
GB9621836D0 (en) * 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9624562D0 (en) * 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives
GB9625865D0 (en) * 1996-12-12 1997-01-29 Zeneca Ltd Peptides
GB9809021D0 (en) * 1998-04-29 1998-06-24 Zeneca Ltd Chemical process
US6262080B1 (en) 1998-12-31 2001-07-17 Avantis Pharmaceuticals Inc. 3-(thio-substitutedamido)-lactams useful as inhibitors of matrix metalloproteinase
ATE233259T1 (de) * 1998-12-31 2003-03-15 Aventis Pharma Inc 3-(thio-substituierte amido)-lactame, verwendbar als inhibitoren der matrix-metalloproteinase
GB9912911D0 (en) * 1999-06-04 1999-08-04 Zeneca Ltd Chemical process
US6485740B1 (en) * 2000-03-14 2002-11-26 Yutoku Pharmaceutical Ind., Co., Ltd. Transdermal methotrexate preparations
GB0017979D0 (en) * 2000-07-22 2000-09-13 Astrazeneca Ab Chemical process
GB0130286D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0130285D0 (en) 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0317733D0 (en) * 2003-07-29 2003-09-03 Novartis Ag Organic compounds
EP2366448B1 (en) * 2010-03-16 2016-07-27 Amminex Emissions Technology A/S Method and device for controlled dosing of a gas with fluctuating supply pressure
PL2920197T3 (pl) * 2012-09-26 2021-09-13 President And Fellows Of Harvard College Peptydy zszywane blokowane proliną i ich zastosowania

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474778A (en) * 1983-11-09 1984-10-02 E. R. Squibb & Sons, Inc. Lactam containing compounds, their pharmaceutical compositions and method of use
US4680283A (en) * 1984-09-26 1987-07-14 Merck & Co., Inc. Analogs of substance P and eledoisin
DE3711335A1 (de) * 1987-04-03 1988-10-20 Merck Patent Gmbh Aminosaeurederivate
US5331089A (en) * 1988-03-25 1994-07-19 Merck Sharpe & Dohme, Ltd. Peptides useful as tachykinin agonists
EP0360390A1 (en) * 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactam derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
AU8305491A (en) * 1990-08-01 1992-03-02 Cytel Corporation Novel immunosuppressant peptides
DE4034829A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh Cyclopeptide
WO1993005011A1 (en) * 1991-08-29 1993-03-18 Sandoz Ltd. Novel immunosuppressants
DK0644197T3 (da) * 1993-06-04 1999-06-07 Vertex Pharma Peptidphosphinyloxymethylketoner som inhibitorer af interleukin-1beta-konverterende enzymer
CN1135181A (zh) * 1993-09-14 1996-11-06 Cytel有限公司 使用泛dr结合肽改变免疫应答
AU2238395A (en) * 1994-04-01 1995-10-23 Immulogic Pharmaceutical Corporation Haptenated peptides and uses thereof
WO1996030035A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS
WO1997016425A1 (en) * 1995-10-30 1997-05-09 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
US5719296A (en) * 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives

Also Published As

Publication number Publication date
ATE196152T1 (de) 2000-09-15
DE69703032D1 (de) 2000-10-12
ES2151716T3 (es) 2001-01-01
DK0882066T3 (da) 2000-12-18
JP2000508623A (ja) 2000-07-11
EP0882066A1 (en) 1998-12-09
WO1997031023A1 (en) 1997-08-28
PT882066E (pt) 2000-12-29
US6087336A (en) 2000-07-11
AU722877B2 (en) 2000-08-10
IL125804A0 (en) 1999-04-11
HK1015383A1 (en) 1999-10-15
NZ330944A (en) 2000-04-28
NO983849D0 (no) 1998-08-21
HRP970099A2 (en) 1998-04-30
DE69703032T2 (de) 2001-04-12
KR19990087123A (ko) 1999-12-15
AU1803597A (en) 1997-09-10
CA2242809A1 (en) 1997-08-28
HUP9901189A3 (en) 2000-07-28
BR9707720A (pt) 1999-04-06
CZ266398A3 (cs) 1998-11-11
HU222198B1 (hu) 2003-05-28
ID16037A (id) 1997-08-28
PL328486A1 (en) 1999-02-01
NO983849L (no) 1998-10-21
AU722877C (en) 2002-12-05
TR199801614T2 (xx) 1998-11-23
CN1213379A (zh) 1999-04-07
CN1116305C (zh) 2003-07-30
GB9702377D0 (en) 1997-03-26
HUP9901189A2 (hu) 1999-08-30
TW492978B (en) 2002-07-01
AR005974A1 (es) 1999-07-21
EP0882066B1 (en) 2000-09-06
SK114998A3 (en) 1999-02-11
GR3034361T3 (en) 2000-12-29
JP3468528B2 (ja) 2003-11-17

Similar Documents

Publication Publication Date Title
HRP970618A2 (en) Antiviral peptide derivatives
HRP970174B1 (en) 6-phenylpyridil-2-amine derivatives
AP9701156A0 (en) 6-phenylpyridyl-2-amine derivatives
IL127332A0 (en) Peptide derivatives
HK1015383A1 (en) Peptide derivatives
GB9624562D0 (en) Peptide derivatives
GB9604996D0 (en) Benzodiazonine derivatives
EP0850950A4 (en) PEPTIDE DERIVATIVES
ZA9711392B (en) Cyclic peptide derivatives
EP0861849A4 (en) PEPTIDE DERIVATIVES
GB9600063D0 (en) Guaridine derivatives
GB9603226D0 (en) Heterocyclyl-ergoline derivatives
GB9702049D0 (en) Tetrahhydroisoquinoline derivatives
GB9709607D0 (en) Peptide derivatives
GB9603855D0 (en) Peptide derivatives
GB9611881D0 (en) Peptide derivatives
SI0882066T1 (en) Peptide derivatives
HU9601036D0 (en) Aryl-sulfonyl-hydroxamic-acid derivatives
GB9713361D0 (en) Peptide derivatives
AU2233497A (en) Peptide derivatives
GB9625227D0 (en) Peptides
GB9608430D0 (en) Peptides
GB9626362D0 (en) Peptides
GB9612648D0 (en) Peptides
SG55039A1 (en) Peptides

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20030108

Year of fee payment: 7

PNAN Change of the applicant name, address/residence

Owner name: SYNGENTA LIMITED,\NSYNGENTA EUROPEAN REGIONAL CENT

PPPP Transfer of rights

Owner name: ASTRAZENECA UK LIMITED, GB

PBON Lapse due to non-payment of renewal fee

Effective date: 20040222